These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37341983)

  • 1. Income differences between locations of 340B entities and contract pharmacies.
    Masia N; Kuwonza F
    Am J Manag Care; 2023 Jun; 29(6):e184-e188. PubMed ID: 37341983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of the 340B Drug Pricing Program: A Scoping Review.
    Knox RP; Wang J; Feldman WB; Kesselheim AS; Sarpatwari A
    JAMA Health Forum; 2023 Nov; 4(11):e233716. PubMed ID: 37991784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 340B Contract pharmacy growth by pharmacy ownership: 2009-2022.
    McGlave C; Bruno JP; Watts E; Nikpay S
    Health Aff Sch; 2024 Jan; 2(1):qxad075. PubMed ID: 38756399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 340b Program, Contract Pharmacies, Hospitals, and Patients: An Evolving Relationship Impacting Health Care Delivery.
    Ruley M; Belcher M; Sayre H; Coustasse A
    Health Care Manag (Frederick); 2019; 38(4):311-321. PubMed ID: 31663869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of 340B contract pharmacy growth with county-level characteristics.
    Nikpay S; Gracia G; Geressu H; Conti R
    Am J Manag Care; 2022 Mar; 28(3):133-136. PubMed ID: 35404549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges for Managed Care from 340B Contract Pharmacies.
    Fein AJ
    J Manag Care Spec Pharm; 2016 Mar; 22(3):197-203. PubMed ID: 27003548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geosocial Factors Associated With Adherence to Statin Medications.
    Erickson SR; Bravo M; Tootoo J
    Ann Pharmacother; 2020 Dec; 54(12):1194-1202. PubMed ID: 32522004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Services provided by community pharmacies in Wayne County, Michigan: a comparison by ZIP code characteristics.
    Erickson SR; Workman P
    J Am Pharm Assoc (2003); 2014; 54(6):618-24. PubMed ID: 25379982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accessibility of adult immunizations in pharmacies compared to physician offices in low-income communities.
    Popovian R; Winegarden W; Rivera E; Gavigan K
    J Am Pharm Assoc (2003); 2022; 62(5):1644-1647. PubMed ID: 35491381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.
    Conti RM; Nikpay SS; Buntin MB
    JAMA Netw Open; 2019 Oct; 2(10):e1914141. PubMed ID: 31664442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of medication access services at 340B and non-340B hospitals.
    Rana I; von Oehsen W; Nabulsi NA; Sharp LK; Donnelly AJ; Shah SD; Stubbings J; Durley SF
    Res Social Adm Pharm; 2021 Nov; 17(11):1887-1892. PubMed ID: 33846100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographic proximity to specialized pediatric neurosurgical care in the contiguous United States.
    Ahmed AK; Duhaime AC; Smith TR
    J Neurosurg Pediatr; 2018 Apr; 21(4):434-438. PubMed ID: 29350592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012.
    Clark BL; Hou J; Chou CH; Huang ES; Conti R
    Health Aff (Millwood); 2014 Nov; 33(11):2012-7. PubMed ID: 25367997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in prescription opioid analgesic availability: comparing minority and white pharmacies across Michigan.
    Green CR; Ndao-Brumblay SK; West B; Washington T
    J Pain; 2005 Oct; 6(10):689-99. PubMed ID: 16202962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 340B Drug Pricing Program and hospital provision of uncompensated care.
    Desai SM; McWilliams JM
    Am J Manag Care; 2021 Oct; 27(10):432-437. PubMed ID: 34668672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to pharmacies and pharmacy services in New York City, Los Angeles, Chicago, and Houston, 2015-2020.
    Guadamuz JS; Alexander GC; Zenk SN; Kanter GP; Wilder JR; Qato DM
    J Am Pharm Assoc (2003); 2021; 61(6):e32-e41. PubMed ID: 34366287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a $4 generic drug program in a 340B pharmacy.
    Bright DR; Adams AJ; Akala FO; Lengel AJ; Martin SJ; Powers MF
    Am J Health Syst Pharm; 2010 Jun; 67(11):929-31. PubMed ID: 20484217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting bargaining outcomes between pharmacies and insurers.
    Brooks JM; Doucette W; Sorofman B
    Health Serv Res; 1999 Apr; 34(1 Pt 2):439-51. PubMed ID: 10199687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication synchronization adoption and pharmacy performance.
    Renfro CP; Turner K; Seeto J; Ferreri SP
    Res Social Adm Pharm; 2021 Aug; 17(8):1496-1500. PubMed ID: 33234452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists' role in reducing racial/ethnic disparities in influenza vaccinations in New York City.
    Crawford ND; Blaney S; Amesty S; Rivera AV; Turner AK; Ompad DC; Fuller CM
    J Urban Health; 2011 Feb; 88(1):176-85. PubMed ID: 21279450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.